Physician

Gregory Glenn Messenger, M.D.

According to 2025 Medicare claims, Gregory Messenger, M.D. (NPI: 1851340012) practices dermatology in the Lansing-East Lansing, MI market, with the plurality of this provider's patient population coming from Ingham, MI. This provider's primary affiliated billing organization is COMPASS HEALTHCARE, PLLC (NPI: 1932533692; TIN: 45-0817179) and primary practice location at 48912-3753. Messenger is affiliated with the POM ACO (ACO ID: A1297), West Michigan Accountable Care Organization, LLC (ACO ID: A4626), Aledade 57 Western Sky MSSP Enhanced (ACO ID: A4756), and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Messenger's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,736 traditional Medicare patients, billed 8,671 HCPCS/CPT codes, and received $297,311 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 5,542 prescription claims across 2,202 beneficiaries totaling $1,246,996 in drug costs, led by Bimzelx Autoinjector (Bimekizumab-Bkzx). Open Payments data shows 17 records totaling $448. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $702,051 to $297,311. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $383,809 to $1,246,996. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	3,346	15,783	$702,051
2016	3,339	15,260	$583,485
2017	2,987	13,411	$490,131
2018	2,931	11,656	$501,477
2019	3,201	14,877	$626,053
2020	2,260	10,617	$411,712
2021	2,099	9,471	$389,210
2022	2,123	9,229	$353,925
2023	1,968	8,692	$330,947
2024	1,736	8,671	$297,311

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,302	2,753	$383,809
2016	1,285	2,887	$416,913
2017	1,235	2,684	$459,040
2018	1,296	2,796	$384,386
2019	1,512	3,219	$409,853
2020	1,623	4,063	$746,789
2021	1,944	4,608	$857,517
2022	1,981	4,655	$928,531
2023	2,100	4,848	$931,176
2024	2,202	5,542	$1,246,996

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17110	Destruction of skin growth, 1-14 growths	395	429	$69
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	766	1,000	$57
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	532	633	$36
17000	Destruction of precancer skin growth, 1 growth	648	746	$34
17003	Destruction of precancer skin growth, 2-14 growths	499	2,616	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Bimzelx Autoinjector	Bimekizumab-Bkzx	17	588	$244,181
Dupixent Pen	Dupilumab	29	812	$110,172
Cosentyx Sensoready (2 Pens)	Secukinumab	15	420	$106,787
Xeljanz	Tofacitinib Citrate	15	300	$87,033
Cosentyx Unoready Pen	Secukinumab	12	336	$85,734

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	17	$448	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Gregory Glenn Messenger, M.D.?

Tedicare shows public-source Medicare data for Gregory Glenn Messenger, M.D. (NPI 1851340012), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gregory Glenn Messenger, M.D. have ACO affiliation data?

Gregory Glenn Messenger, M.D. is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297), West Michigan Accountable Care Organization, LLC (MSSP, ACO ID A4626), Aledade 57 Western Sky MSSP Enhanced (MSSP, ACO ID A4756), and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Gregory Glenn Messenger, M.D.?

Gregory Glenn Messenger, M.D. is linked to COMPASS HEALTHCARE, PLLC (billing NPI 1932533692) in the available physician profile data.

Does Gregory Glenn Messenger, M.D. have Open Payments data?

Gregory Glenn Messenger, M.D. has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.